Sildenafil Is More Selective Pulmonary Vasodilator than PGE1 in Patients with Severe Pulmonary Hypertension Secondary to Heart Failure

被引：0
|
作者：
Al-Hiti, H. [1 ]
Melenovsky, V. [1 ]
Kettner, J. [1 ]
Kautzner, J. [1 ]
机构：
[1] IKEM, Prague, Czech Republic
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2010年 / 29卷 / 02期
关键词：
D O I：
10.1016/j.healun.2009.11.217
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
206
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [21] Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension
    Dumitrescu, Daniel
    Seck, Catherine
    Moehle, Luise
    Erdmann, Erland
    Rosenkranz, Stephan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 154 (02) : 205 - 206
  • [22] Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension
    Lewis, Gregory D.
    Shah, Ravi
    Shahzad, Khurram
    Camuso, Janice M.
    Pappagianopoulos, Paul P.
    Hung, Judy
    Tawakol, Ahmed
    Gerszten, Robert E.
    Systrom, David M.
    Bloch, Kenneth D.
    Semigran, Marc J.
    CIRCULATION, 2007, 116 (14) : 1555 - 1562
  • [23] Aerosolized PGE1:: A selective pulmonary vasodilator in neonatal hypoxemic respiratory failure results of a phase I/II open label clinical
    Sood, BG
    Delaney-Black, V
    Aranda, JV
    Shankaran, S
    PEDIATRIC RESEARCH, 2004, 56 (04) : 579 - 585
  • [24] Inhaled nitric oxide: more than a selective pulmonary vasodilator
    Gianetti, J
    Bevilacqua, S
    De Caterina, R
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (08) : 628 - 635
  • [25] Sildenafil And Riociguat Ameliorates Secondary Pulmonary Hypertension In A Murine Model Of Left Heart Failure
    Pradhan, K.
    Sydykov, A.
    Arakelyan, K.
    Weissmann, N.
    Seeger, W.
    Grimminger, F.
    Kretschmer, A.
    Stasch, J. -P.
    Schermuly, R.
    Ghofrani, H. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [26] The Feasibility of Noninvasive Mechanical Ventilation Combined with PGE1 in the Treatment of Severe Pulmonary Heart Disease Complicated with Respiratory Failure
    Xu, Ruishan
    Zhang, Xiaoli
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 : 399 - 400
  • [27] Impact of sildenafil treatment on pulmonary hemodynamics and outcomes in patients with severe pulmonary hypertension receiving heart transplantation
    Senechal, M.
    Pons, J.
    Bernier, M.
    Cantin, B.
    Bourgault, C.
    Bergeron, S.
    Proulx, G.
    Nalli, C.
    Chateauvert, N.
    Leblanc, M. H.
    EUROPEAN HEART JOURNAL, 2012, 33 : 207 - 207
  • [28] Sildenafil in Patients with Severe Group 3 Pulmonary Hypertension
    Price, Laura
    Kempny, Aleksander
    Mccabe, Colm
    Dimopoulos, Kostantinos
    Kotecha, Jalpa
    Harries, Carl
    Barbosa, Joana
    Hopkinson, Nick
    Simonds, Anita
    Wells, Athol
    Wort, John
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [29] Aerosolized PGE1: A Selective Pulmonary Vasodilator in Neonatal Hypoxemic Respiratory Failure Results of a Phase I/II Open Label Clinical Trial
    Beena G Sood
    Virginia Delaney-Black
    Jacob V Aranda
    Seetha Shankaran
    Pediatric Research, 2004, 56 : 579 - 585
  • [30] Descriptive study of patients diagnosed with type 2 pulmonary hypertension receving sildenafil in heart failure and pulmonary hypertension clinics
    Lujan Valencia, J.
    Blanco Ponce, E.
    Fernandez Vivancos, C.
    Gonzalez Matos, C.
    Caravaca Perez, P.
    Garcia Guerrero, A.
    Gomez Dominguez, R.
    Butron Calderon, M.
    Perez Rodriguez, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 114 - 114
12345